(Press-News.org) BATON ROUGE – Ochsner Baton Rouge has opened the new Ochsner Outpatient and Home Infusion Pharmacy – Baton Rouge at 4730 Bluebonnet Blvd., Suite 401. This advanced facility provides treatment for chronic, specialty and acute home infusions.
The pharmacy is conveniently located and designed with patient comfort and accessibility in mind. Each of its six patient rooms offers a spa-like environment, providing patient care in a peaceful, supportive setting that promotes healing. Ochsner’s pharmacists work closely with patients’ healthcare providers to create customized treatment plans, ensuring personalized and effective care.
“We’re opening the doors to a new facility, but we’re also unlocking greater possibilities for patient care in Baton Rouge,” says Chuck Daigle, Ochsner Baton Rouge CEO. “This center is designed to meet today’s healthcare needs and to anticipate and adapt to the future of healthcare. We continually strive for the best way to serve patients.”
Infusion services offer intravenous, or IV, treatment to cure or control a variety of medical conditions. They also offer palliative care, which focuses on relieving symptoms and improved quality of life for patients with chronic illnesses like cancer.
Ochsner infusion centers are certified by the American College of Surgeons Commission on Cancer, the Quality Oncology Practice Initiative and The Joint Commission. Ochsner’s certified chemotherapy infusion units have earned designations through the American Society of Clinical Oncology.
To schedule an appointment at any Ochsner location, call 866-624-7637 or visit www.ochsner.org/info. Online appointments are available through the MyOchsner patient portal.
###
About Ochsner Health
Ochsner Health is the leading not-for-profit healthcare provider in the Gulf South, delivering expert care at its 46 hospitals and more than 370 health and urgent care centers. For 12 consecutive years, U.S. News & World Report has recognized Ochsner as the No. 1 hospital in Louisiana. Additionally, Ochsner Children’s has been recognized as the No. 1 hospital for kids in Louisiana for three consecutive years. Ochsner inspires healthier lives and stronger communities through a combination of standard-setting expertise, quality and connection not found anywhere else in the region. In 2023, Ochsner Health cared for more than 1.5 million people from every state in the nation and 65 countries. Ochsner’s workforce includes more than 38,000 dedicated team members and over 4,700 employed and affiliated physicians. To learn more about how Ochsner empowers people to get well and stay well, visit https://www.ochsner.org/.
BATON ROUGE – Ochsner Baton Rouge has opened the new Ochsner Outpatient and Home Infusion Pharmacy – Baton Rouge at 4730 Bluebonnet Blvd., Suite 401. This advanced facility provides treatment for chronic, specialty and acute home infusions.
The pharmacy is conveniently located and designed with patient comfort and accessibility in mind. Each of its six patient rooms offers a spa-like environment, providing patient care in a peaceful, supportive setting that promotes healing. Ochsner’s pharmacists work closely with patients’ healthcare providers to create customized treatment plans, ensuring personalized and effective care.
“We’re opening the doors to a new facility, but we’re also unlocking greater possibilities for patient care in Baton Rouge,” says Chuck Daigle, Ochsner Baton Rouge CEO. “This center is designed to meet today’s healthcare needs and to anticipate and adapt to the future of healthcare. We continually strive for the best way to serve patients.”
Infusion services offer intravenous, or IV, treatment to cure or control a variety of medical conditions. They also offer palliative care, which focuses on relieving symptoms and improved quality of life for patients with chronic illnesses like cancer.
Ochsner infusion centers are certified by the American College of Surgeons Commission on Cancer, the Quality Oncology Practice Initiative and The Joint Commission. Ochsner’s certified chemotherapy infusion units have earned designations through the American Society of Clinical Oncology.
To schedule an appointment at any Ochsner location, call 866-624-7637 or visit www.ochsner.org/info. Online appointments are available through the MyOchsner patient portal.
###
About Ochsner Health
Ochsner Health is the leading not-for-profit healthcare provider in the Gulf South, delivering expert care at its 46 hospitals and more than 370 health and urgent care centers. For 12 consecutive years, U.S. News & World Report has recognized Ochsner as the No. 1 hospital in Louisiana. Additionally, Ochsner Children’s has been recognized as the No. 1 hospital for kids in Louisiana for three consecutive years. Ochsner inspires healthier lives and stronger communities through a combination of standard-setting expertise, quality and connection not found anywhere else in the region. In 2023, Ochsner Health cared for more than 1.5 million people from every state in the nation and 65 countries. Ochsner’s workforce includes more than 38,000 dedicated team members and over 4,700 employed and affiliated physicians. To learn more about how Ochsner empowers people to get well and stay well, visit https://www.ochsner.org/.
END
Ochsner Baton Rouge opens new outpatient infusion pharmacy
2024-05-16
ELSE PRESS RELEASES FROM THIS DATE:
When saying “please” is more strategic than magic
2024-05-16
Key takeaways
A new study by UCLA sociologists found that using the word “please” does not always indicate respect or politeness.
In the study, “please” was used only 7% of the time, mostly when there was an inhospitable interactional environment to overcome.
Findings will help researchers in their understanding of politeness in the flow of social behavior and norms.
By kindergarten age, most children have been taught that “please” is a magic word. “Please” is an expression of politeness that shows courtesy and respect, turning a potential demand into a request that will – ...
Nature Conferences, Davos Alzheimer’s Collaborative, Aga Khan University launch Africa’s first-ever dementia conference to advance lifespan brain health innovations across diverse communities
2024-05-16
The Davos Alzheimer’s Collaborative (DAC), the organization leading an unprecedented global response to Alzheimer’s, today announced the first-ever brain health and dementia conference in Africa, held in Nairobi, Kenya from September 11-12 in partnership with Nature Conferences and the Aga Khan University’s Brain & Mind Institute. The conference, “The Future of Dementia in Africa: Advancing Global Partnerships,” focuses on scientific advancements in understanding the impact of dementia, risk ...
Climate change likely to aggravate brain conditions
2024-05-16
Climate change, and its effects on weather patterns and adverse weather events, is likely to negatively affect the health of people with brain conditions, argue a UCL-led team of researchers.
In a Personal View article, published in The Lancet Neurology, the team emphasise the urgent need to understand the impact of climate change on people with neurological conditions – in order to preserve their health and prevent worsening inequalities.
Following a review of 332 papers published across the world between 1968 and 2023, the team, led by Professor Sanjay Sisodiya (UCL Queen Square Institute of Neurology), said they expect the scale of the potential ...
Updated medical guidance on “excited delirium” brought forward
2024-05-16
Updated medical guidance on excited delirium, the controversial term accused of covering up deaths in police custody, including that of George Floyd, is being brought forward before its scheduled date of October 2025, reports The BMJ today.
The move comes as attitudes towards the use of the term appear to be changing, explains journalist Chris Stokel-Walker. For instance, last month Colorado joined California in banning police, medical staff and coroners from using the term, and the UK Independent ...
New study shows continued high effectiveness of HPV vaccination in England
2024-05-16
The human papillomavirus (HPV) vaccination programme in England has not only been associated with a substantial reduction in cervical disease, but has done so in all socioeconomic groups, finds a study published by The BMJ today.
Although women living in the most deprived areas are still at higher risk of cervical disease than those in less deprived areas, the results show that well planned and executed public health interventions can both improve health and reduce health inequalities.
HPV ...
HPV vaccine prevents most cervical cancer cases in more deprived groups, major study shows
2024-05-16
Strict embargo: 23.30 hrs BST
Wednesday, 15 May, 2024
Peer-reviewed
Observational
People
The human papillomavirus, or HPV, vaccine is cutting cases of cervical cancer right across the socio-economic spectrum, with most cases being prevented in more deprived groups, according to a major study funded by Cancer Research UK.
Until now, there had been concerns that the HPV vaccine could have an unequal impact across society. After carrying out the longest follow-up on the effectiveness of the HPV vaccine, researchers at Queen Mary University of London concluded the HPV vaccination programme in England is helping to close some inequalities ...
Radiation-based immunogenic vaccine combined with a macrophage “checkpoint inhibitor” for boosting innate and adaptive immunity against metastatic colon cancers
2024-05-15
https://doi.org/10.1016/j.apsb.2024.02.015
This new article publication from Acta Pharmaceutica Sinica B, discusses how the use of a radiation-based immunogenic vaccine combined with a macrophage “checkpoint inhibitor” can boost innate and adaptive immunity against metastatic colon cancers.
Immunogenic dying tumor cells hold promising prospects as cancer vaccines to activate systemic immunity against both primary and metastatic tumors. Especially, X-ray- induced dying tumor cells are rich in highly immunogenic tumor-associated antigens ...
Branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy
2024-05-15
https://doi.org/10.1016/j.apsb.2024.02.006
This new article publication from Acta Pharmaceutica Sinica B, discusses how branched glycopolymer prodrug-derived nanoassembly combined with a STING agonist activates an immuno-supportive status to boost anti-PD-L1 antibody therapy.
Despite the great potential of anti-PD-L1 antibodies for immunotherapy, their low response rate due to an immunosuppressive tumor microenvironment has hampered their application.
To address this issue, the authors of this article constructed a cell membrane-coated nanosystem (mB4S) to reverse an immunosuppressive microenvironment to an immuno-supportive ...
5S-Heudelotinone alleviates experimental colitis by shaping the immune system and enhancing the intestinal barrier in a gut microbiota-dependent manner
2024-05-15
https://doi.org/10.1016/j.apsb.2024.02.020
This new article publication from Acta Pharmaceutica Sinica B, discusses how 5S-Heudelotinone alleviates experimental colitis by shaping the immune system and enhancing the intestinal barrier in a gut microbiota-dependent manner.
Aberrant changes in the gut microbiota are implicated in many diseases, including inflammatory bowel disease (IBD). Gut microbes produce diverse metabolites that can shape the immune system and impact the intestinal barrier integrity, indicating that microbe-mediated modulation may be a promising strategy for preventing and treating IBD.
Although ...
ALS-linked C9orf72 dipeptide repeats inhibit starvation-induced autophagy through modulating BCL2–BECN1 interaction
2024-05-15
https://doi.org/10.1016/j.apsb.2024.02.004
This new article publication from Acta Pharmaceutica Sinica B, discusses how ALS-linked C9orf72 dipeptide repeats inhibit starvation-induced autophagy through modulating BCL2–BECN1 interaction.
Growing evidence indicate that dysfunction of autophagy contributes to the disease pathogenesis of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), two neurodegenerative disorders. The GGGGCC·GGCCCC repeat RNA expansion in chromosome 9 open reading frame 72 (C9orf72) ...